Dechra Pharmaceuticals PLC
20 January 2006
Dechra Pharmaceuticals PLC ('the Company')
Holding(s) in Company
The Company was notified 20 January 2006 by Barclays PLC that through the legal
entities of Barclays Global Investors Ltd, Barclays Capital Securities Ltd,
Barclays Life Assurance Co Ltd and Gerrard Ltd, Barclays PLC has a notifiable
interest in 2,843,036 ordinary shares of 1p each in the Company ('Ordinary
Shares'), representing approximately 5.53 per cent. of the Company's issued
ordinary share capital. These Ordinary Shares are registered as follows:
Registered Holder Ordinary Shares
Barclays Capital Nominees Limited 571,658
Chase Nominees Ltd a/c 16376 28,830
Chase Nominees Ltd a/c 21359 110,792
Chase Nominees Ltd a/c 28270 18,742
Chase Nominees Ltd a/c 28270 27,222
JP Morgan (BGI Custody) a/c 16341 36,065
JP Morgan (BGI Custody) a/c 16341 62,361
JP Morgan (BGI Custody) a/c 16344 21,055
JP Morgan (BGI Custody) a/c 16345 35,216
JP Morgan (BGI Custody) a/c 16400 386,797
JP Morgan (BGI Custody) a/c 16480 1,273,190
JP Morgan (BGI Custody) a/c 16482 240,248
JP Morgan (BGI Custody) a/c 18409 29,412
R C Greig Nominees Limited a/c 1,448
Total 2,843,036
20 January 2006
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.